# Medirom Healthcare Technologies Files 2025 Form 20-F and Appeals Nasdaq Delisting Determination

> Medirom filed its 2025 Form 20-F on November 18, 2026 and appealed Nasdaq's delisting determination, winning a 15-day stay as an April 5.

- Published: 2026-11-18T22:12:27+00:00
- Section: Regulation & Approvals
- Author: News Desk
- URL: https://newsforagent.com/news/2026-11-18/medirom-files-20-f-appeals-nasdaq-delisting
- Source: [TradingView](https://www.tradingview.com/news/tradingview:8af390b9c0240:0-medirom-healthcare-technologies-inc-mrm-files-report-appeals-nasdaq-delisting/)

## Key takeaways

- Medirom Healthcare Technologies filed its 2025 Form 20-F on November 18, 2026 and requested a hearing to appeal Nasdaq's delisting determination.
- The hearing request automatically stays any suspension for 15 days, while a separate minimum bid-price deficiency carries an April 5, 2027 deadline.
- Flux Power received a Nasdaq noncompliance notice on November 9, 2026 over a $431,000 equity deficit and has until December 24, 2026 to submit a compliance plan.

Medirom Healthcare Technologies filed its 2025 Form 20-F on November 18, 2026 and requested a hearing to appeal [Nasdaq](https://akta.pro/company-profiles/00000si/nasdaq)'s delisting determination, [TradingView](https://www.tradingview.com/news/tradingview:8af390b9c0240:0-medirom-healthcare-technologies-inc-mrm-files-report-appeals-nasdaq-delisting/) reported. The hearing request automatically stays any suspension for 15 days. A separate minimum bid-price deficiency remains outstanding, with an April 5, 2027 deadline.

## Medirom's Filing and the Nasdaq Appeal

[Medirom Healthcare Technologies](https://akta.pro/company-profiles/0000cyy/medirom-healthcare-technologies) is a Japan-based healthcare and wellness operator running roughly 300 Re.Ra.Ku relaxation studios alongside its MOTHER Bracelet wearables, REMONY remote health monitoring and a World ID verification partnership, according to [company records](https://akta.pro/company-data). The company filed its 2025 annual report on Form 20-F on November 18, 2026, the same day it asked for a hearing to challenge Nasdaq's delisting determination.

The appeal buys time rather than resolution. The automatic stay protects trading for 15 days, and any further stay depends on the hearing process. The annual report filing supports the appeal, though Nasdaq may not treat the reporting deficiency as resolved. The bid-price shortfall is a separate listing requirement that the Form 20-F does not address.

Nasdaq has its own operational priorities in the same period. Executive vice chairman Edward S Knight said the exchange plans to launch 23-hour-a-day, five-day-a-week US equity trading on December 6, Devdiscourse reported.

## Medirom's Funding and Partnership Record

Medirom's records show three funding rounds, including a $2.3 million post-IPO debt round in March 2025 and a $5 million post-IPO equity round in December 2024, according to akta.pro funding records. A December 2025 distributor agreement with TD SYNNEX K.K. covers the MOTHER Bracelet and REMONY system in Japan. A Master Service Agreement with Tools for Humanity, effective February 2, 2026, targets World ID verification across approximately 3,000 locations, with up to roughly $39 million in pre-tax operating income over two years if that target is reached.

## Flux Power's Nasdaq Noncompliance Notice

[Flux Power](https://www.tradingview.com/news/tradingview:2ab2f5650cbb1:0-flux-power-received-notice-of-noncompliance/) received a Nasdaq notice on November 9, 2026 that it no longer meets Listing Rule 5550(b)(1) because of a $431,000 equity deficit, TradingView reported. The company has until December 24, 2026 to submit a compliance plan, and its shares continue trading under the ticker FLUX. Kazakhstan, meanwhile, is weighing a unified strategy for the Kazakhstan Stock Exchange, the Astana International Financial Center and Alatau City, [The Astana Times](https://astanatimes.com/2026/11/kazakhstan-considers-unified-strategy-for-three-financial-platforms/) reported on November 13, 2026.

## Medirom's April 2027 Bid-Price Deadline

Medirom faces an April 5, 2027 deadline to meet the minimum bid-price requirement. Nasdaq's response to the filing and the Panel's decision on a further stay and continued listing are the steps the company has disclosed.

## Companies in this story

- [Medirom Healthcare Technologies company profile](https://akta.pro/company-profiles/0000cyy/medirom-healthcare-technologies) · website: https://medirom.co.jp
- [Nasdaq company profile](https://akta.pro/company-profiles/00000si/nasdaq) · website: https://www.nasdaq.com

---
News for Agent · https://newsforagent.com/llms.txt
